PCM
Penserra Capital Management Portfolio holdings
AUM
$7.17B
1-Year Return
49.58%
This Quarter Return
+33.7%
1 Year Return
+49.58%
3 Year Return
+118.16%
5 Year Return
+229.83%
10 Year Return
–
AUM
$4.23B
AUM Growth
+$1.6B
(+61%)
Cap. Flow
+$935M
Cap. Flow
% of AUM
22.08%
Top 10 Holdings %
Top 10 Hldgs %
21.32%
Holding
1,174
New
230
Increased
606
Reduced
167
Closed
168
Top Buys
| 1 |
KE Holdings
BEKE
|
+$78.6M |
| 2 |
Lufax Holding
LU
|
+$56.6M |
| 3 |
Groupon
GRPN
|
+$50.3M |
| 4 |
JD.com
JD
|
+$43.7M |
| 5 |
Lands' End
LE
|
+$36.7M |
Top Sells
| 1 |
JMIA
Jumia Technologies
JMIA
|
+$35.9M |
| 2 |
Peloton Interactive
PTON
|
+$31.3M |
| 3 |
Match Group
MTCH
|
+$23.5M |
| 4 |
Fiverr
FVRR
|
+$16.6M |
| 5 |
Stitch Fix
SFIX
|
+$14.7M |
Sector Composition
| 1 | Consumer Discretionary | 35.59% |
| 2 | Technology | 23.48% |
| 3 | Communication Services | 13.86% |
| 4 | Real Estate | 4.37% |
| 5 | Industrials | 4.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Aon
AON
$79B
| $101K | ﹤0.01% |
+481
| New | +$101K |
|
602
Eaton
ETN
$136B
| $101K | ﹤0.01% |
849
+169
| +25% | +$20.1K |
|
603
Apellis Pharmaceuticals
APLS
$3.39B
| $100K | ﹤0.01% |
1,750
+1,104
| +171% | +$63.1K |
|
604
Capital One
COF
$142B
| $100K | ﹤0.01% |
1,030
+282
| +38% | +$27.4K |
|
605
Editas Medicine
EDIT
$248M
| $100K | ﹤0.01% |
1,430
+898
| +169% | +$62.8K |
|
606
Moody's
MCO
$91.1B
| $100K | ﹤0.01% |
345
+73
| +27% | +$21.2K |
|
|
CCXI
607
DELISTED
ChemoCentryx, Inc.
CCXI
| $98K | ﹤0.01% |
1,590
+1,000
| +169% | +$61.6K |
|
608
PTC Therapeutics
PTCT
$4.64B
| $95K | ﹤0.01% |
1,565
+987
| +171% | +$59.9K |
|
609
Cognizant
CTSH
$34.6B
| $94K | ﹤0.01% |
1,151
+233
| +25% | +$19K |
|
610
HCA Healthcare
HCA
$96.7B
| $92K | ﹤0.01% |
561
+119
| +27% | +$19.5K |
|
611
Electronic Arts
EA
$41.5B
| $87K | ﹤0.01% |
610
+100
| +20% | +$14.3K |
|
|
TWTR
612
DELISTED
Twitter, Inc.
TWTR
| $87K | ﹤0.01% |
1,623
-1,594
| -50% | -$85.4K |
|
613
Relay Therapeutics
RLAY
$702M
| $85K | ﹤0.01% |
+2,065
| New | +$85K |
|
|
WTER
614
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
| $83K | ﹤0.01% |
5,497
+606
| +12% | +$9.15K |
|
615
DocuSign
DOCU
$16B
| $82K | ﹤0.01% |
373
-273
| -42% | -$60K |
|
|
RETA
616
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $82K | ﹤0.01% |
+665
| New | +$82K |
|
617
Allogene Therapeutics
ALLO
$253M
| $81K | ﹤0.01% |
3,240
+2,052
| +173% | +$51.3K |
|
|
SWTX
618
DELISTED
SpringWorks Therapeutics
SWTX
| $81K | ﹤0.01% |
+1,125
| New | +$81K |
|
619
Arvinas
ARVN
$587M
| $79K | ﹤0.01% |
935
+599
| +178% | +$50.6K |
|
620
CrowdStrike
CRWD
$106B
| $79K | ﹤0.01% |
374
-220
| -37% | -$46.5K |
|
|
AIV
621
Aimco
AIV
$1.09B
| $78K | ﹤0.01% |
14,901
-69,010
| -82% | -$361K |
|
622
LendingTree
TREE
$988M
| $78K | ﹤0.01% |
286
-11
| -4% | -$3K |
|
623
Vir Biotechnology
VIR
$728M
| $78K | ﹤0.01% |
+2,920
| New | +$78K |
|
624
FibroGen
FGEN
$46.4M
| $77K | ﹤0.01% |
83
+52
| +168% | +$48.2K |
|
625
Insmed
INSM
$31.1B
| $77K | ﹤0.01% |
2,335
+1,469
| +170% | +$48.4K |
|